In both drug-naïve patient melanomas and untreated PDX melanomas, NCSC cells were initially relatively rare, but then following the cell state transitions during BRAF/MEK inhibitor treatment, the NCSC population was enriched, although this subpopulation was reduced in numbers again upon drug withdrawal [42]. This evidence concerns the gene MAP2K7 and melanoma.